| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | 29.345 | 43.123 | 65.235 | 10.323 | 5.714 | 7.591 | - | - |
| Total Income - EUR | - | - | 29.345 | 43.126 | 65.235 | 10.323 | 6.314 | 7.651 | - | - |
| Total Expenses - EUR | - | - | 14.134 | 29.896 | 80.747 | 53.342 | 8.633 | 50.929 | - | - |
| Gross Profit/Loss - EUR | - | - | 15.210 | 13.230 | -15.512 | -43.020 | -2.318 | -43.278 | - | - |
| Net Profit/Loss - EUR | - | - | 14.821 | 12.799 | -16.165 | -43.114 | -2.382 | -43.354 | - | - |
| Employees | - | - | 1 | 1 | 1 | 1 | 1 | 1 | - | - |
Check the financial reports for the company - Apimed Pharma Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | 948 | 1.117 | 1.095 | 1.074 | 1.051 | 1.054 | - | - |
| Current Assets | - | - | 31.724 | 47.805 | 30.464 | 44.279 | 53.563 | 10.896 | - | - |
| Inventories | - | - | 20.368 | 44.764 | 29.001 | 38.291 | 48.294 | 6.862 | - | - |
| Receivables | - | - | 0 | 49 | 48 | 4.509 | 5.140 | 3.906 | - | - |
| Cash | - | - | 11.356 | 2.993 | 1.415 | 1.479 | 129 | 127 | - | - |
| Shareholders Funds | - | - | 28.587 | 40.861 | 23.905 | -19.662 | -21.608 | -65.029 | - | - |
| Social Capital | - | - | 44 | 43 | 42 | 41 | 40 | 41 | - | - |
| Debts | - | - | 4.085 | 8.061 | 7.654 | 65.016 | 76.222 | 76.979 | - | - |
| Income in Advance | - | - | 0 | 0 | 0 | 0 | 0 | 0 | - | - |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4773 - 4773" | |||||||||
| CAEN Financial Year |
4773
|
|||||||||
Comments - Apimed Pharma Srl